You may also like
A Systematic Review and Meta-Analysis of Bivalirudin Application in Peripheral Endovascular Procedures
The direct thrombin inhibitor bivalirudin (BIV) was shown to be superior to unfractionated heparin (UFH) in percutaneous coronary interventions for reducing procedural blood loss. The aim of this study was to compare outcome profiles of BIV and UFH in peripheral endovascular procedures (PEPs) by synthesizing the currently available data.
1 min read
ABIOMED Announces First European Site for AbioCor Implantable Replacement Heart Clinical Trial
ABIOMED, Inc. (NASDAQ:ABMD) today announced that the North Rhine-Westphalia Heart Center, Bad Oeynhausen, Germany will serve as a European clinical trial site […]
2 min read
Quality Control in Blood Management (EP Video)
John Rivera discusses quality control procedures in blood management (34:14 minutes).
1 min read